Key terms
About EOLS
Evolus, Inc. is a medical aesthetics company, which engages in the provision of medical aesthetic treatments and procedures. It offers products under the brand of Jeuveau. The company was founded by Scott Cannizzaro in November 2012 and is headquartered in Newport Beach, CA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest EOLS news
Apr 17
4:06pm ET
Evolus discloses publication of Phase 2 study data of 40U Jeuveau
Apr 03
4:43pm ET
Evolus Inc Announces Strategic Board Renewal Plans
Mar 21
7:34am ET
5 Stocks Hedge Funds Love and have Analysts Support
Mar 21
1:59am ET
Evolus (NASDAQ:EOLS): An Attractive Aesthetics Stock for Growth Investors
Mar 14
5:00am ET
Analysts Offer Insights on Healthcare Companies: Sangamo Biosciences (SGMO) and Evolus (EOLS)
Mar 11
7:25am ET
Evolus 3.55M share Spot Secondary priced at $14.07
Mar 11
2:35am ET
Evolus (EOLS) Receives a Buy from Barclays
Mar 11
2:32am ET
3 Best Stocks to Buy Now, 3/11/2024, According to Top Analysts
Mar 11
12:45am ET
Evolus Poised for Growth: Buy Rating Affirmed with $25 Price Target Amid Profitability Forecast and Competitive Market Positioning
Mar 08
8:25am ET
Evolus price target raised to $25 from $23 at Stifel
Mar 08
6:55am ET
Evolus Poised for Growth: Surpassing Q4 Expectations and Accelerating Profitability
Mar 08
6:41am ET
Evolus price target raised to $23 from $20 at Mizuho
Mar 08
6:27am ET
Evolus: A Promising Trajectory Toward Profitability and Market Expansion
Mar 07
4:30pm ET
Evolus sees FY24 revenue $255M-$265M, consensus $261.17M
Mar 07
4:29pm ET
Evolus reports Q4 EPS (21c), consensus (7c)
Mar 01
12:40pm ET
Analysts Offer Insights on Healthcare Companies: Evolus (EOLS) and Akero Therapeutics (AKRO)
Feb 05
4:20am ET
Analysts Offer Insights on Healthcare Companies: Cigna (CI), Evolus (EOLS) and Hologic (HOLX)
Jan 22
3:40pm ET
Analysts Offer Insights on Healthcare Companies: Evolus (EOLS), Bristol-Myers Squibb (BMY) and Immunocore Holdings (IMCR)
Jan 22
3:30pm ET
Analysts’ Top Healthcare Picks: Instil Bio (TIL), Evolus (EOLS)
Jan 22
3:20pm ET
Analysts’ Top Healthcare Picks: Eli Lilly & Co (LLY), Exelixis (EXEL)
Jan 22
3:01pm ET
Analysts Offer Insights on Healthcare Companies: Lexaria Bioscience (LEXX), Evolus (EOLS) and Inspire Medical Systems (INSP)
EOLS Financials
Key terms
Ad Feedback
EOLS Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
EOLS Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range